Zn-DPA-P

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameZn-DPA-P
Drug Alias Nameprostate cancer imaging agent (Molecular Targeting Technology)
ClassificationDiagnostic agent (In vivo)Small molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMolecular Targeting Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMolecular Targeting Technologies Inc
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A